GLP‑1 Receptor Agonist Use Across Preconception, Pregnancy, and the Postpartum P
GLP-1 RA use in pregnancy remains controversial due to limited human data. This review synthesizes available evidence on risks and benefits across reproductive stages.
Medical Cannabis Evidence-Based Care: Endocannabinoid System Clinical Research and Cannabinoid Dosing in Family Medicine
Prenatal cannabis polysubstance use risks are significant in clinical care, especially when combined with alcohol and other substances. Understanding these patterns helps providers offer targeted counseling and referrals. This evidence-based approach…
Associations of Prenatal Cannabis Exposure and Neonatal Brain Development in the HBCD Cohort.
A major cohort study demonstrates that prenatal cannabis exposure brain development effects are detectable through neuroimaging in newborns. This research provides objective evidence supporting current recommendations to avoid cannabis during pregnancy…
Perceived Safety of Cannabis Use During Pregnancy and Changes in Perception over Time (2017-2021)
This national survey examines perceived cannabis safety pregnancy trends among US adults from 2017 to 2021. Understanding these perceptions is crucial for maternal counseling and fetal health. The study reveals evolving public views that may impact…
Cannabis in Pregnancy: 5 Crucial Insights
The cannabis in pregnancy study reveals important insights for expectant mothers. This research balances scientific evidence with practical guidance on cannabis use during pregnancy. Understanding these findings helps in making informed health decisions.